Literature DB >> 19527225

Neurological comorbidity and epilepsy: implications for treatment.

G Zaccara1.   

Abstract

Epilepsy is a chronic condition that may be associated with several other diseases. In these cases, we should consider the following points: (1) antiepileptic drug (AED) treatment may positively or negatively affect comorbid disease, (2) drugs used for treatment of co-morbid disease may influence seizure threshold, (3) AED toxicity can be affected by a comorbid condition and (4) co-administration of AEDs with drugs used for treatment of comorbid conditions can be associated with clinically relevant drug-drug interactions. In this article, we discuss problems that are usually encountered when an appropriate AED treatment has to be selected in newly diagnosed epileptic patients who also have (an)other neurological disease(s). Comorbidity of epilepsy with cerebrovascular diseases, dementias, mental retardation, attention deficit and hyperactivity disorder, brain tumours, infections of the CNS, migraine, sleep disturbances (obstructive sleep apnoea syndrome), substance abuse and multiple sclerosis is discussed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19527225     DOI: 10.1111/j.1600-0404.2008.01146.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  9 in total

Review 1.  Tolerability of new antiepileptic drugs: a network meta-analysis.

Authors:  Gaetano Zaccara; Fabio Giovannelli; Filippo Sean Giorgi; Valentina Franco; Sara Gasparini; Umberto Benedetto
Journal:  Eur J Clin Pharmacol       Date:  2017-04-04       Impact factor: 2.953

2.  Treatment of refractory epilepsy with natalizumab in a patient with multiple sclerosis. Case report.

Authors:  Stefano Sotgiu; Maria R Murrighile; Gabriela Constantin
Journal:  BMC Neurol       Date:  2010-09-23       Impact factor: 2.474

3.  Uncovering genomic causes of co-morbidity in epilepsy: gene-driven phenotypic characterization of rare microdeletions.

Authors:  Dalia Kasperavičiūtė; Claudia B Catarino; Krishna Chinthapalli; Lisa M S Clayton; Maria Thom; Lillian Martinian; Hannah Cohen; Shazia Adalat; Detlef Bockenhauer; Simon A Pope; Nicholas Lench; Martin Koltzenburg; John S Duncan; Peter Hammond; Raoul C M Hennekam; John M Land; Sanjay M Sisodiya
Journal:  PLoS One       Date:  2011-08-17       Impact factor: 3.240

4.  Accounting for comorbidity in assessing the burden of epilepsy among US adults: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  R C Kessler; M C Lane; V Shahly; P E Stang
Journal:  Mol Psychiatry       Date:  2011-05-17       Impact factor: 15.992

5.  CoVID-19 vs. epilepsy: It is time to move, act, and encourage physical exercise.

Authors:  Rodrigo Luiz Vancini; Claudio Andre Barbosa de Lira; Marília Santos Andrade; Ricardo Mário Arida
Journal:  Epilepsy Behav       Date:  2020-05-03       Impact factor: 2.937

6.  An Explainable Multimodal Neural Network Architecture for Predicting Epilepsy Comorbidities Based on Administrative Claims Data.

Authors:  Thomas Linden; Johann De Jong; Chao Lu; Victor Kiri; Kathrin Haeffs; Holger Fröhlich
Journal:  Front Artif Intell       Date:  2021-05-21

7.  Long-term safety and effectiveness of zonisamide in the treatment of epilepsy: a review of the literature.

Authors:  Gaetano Zaccara; Luigi M Specchio
Journal:  Neuropsychiatr Dis Treat       Date:  2009-05-20       Impact factor: 2.570

8.  Principal component analysis characterizes shared pathogenetics from genome-wide association studies.

Authors:  Diana Chang; Alon Keinan
Journal:  PLoS Comput Biol       Date:  2014-09-11       Impact factor: 4.475

9.  EEG-Brain Activity Monitoring and Predictive Analysis of Signals Using Artificial Neural Networks.

Authors:  Raluca Maria Aileni; Sever Pasca; Adriana Florescu
Journal:  Sensors (Basel)       Date:  2020-06-12       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.